The role is responsible for optimizing drug therapy by identifying and resolving drug-related problems to improve patient outcomes
Job Summary
The role is responsible for optimizing drug therapy by identifying and resolving drug-related problems to improve patient outcomes.
Candidates will develop and enforce policies that promote safe, effective, and cost-efficient use of antineoplastic medications.
Mass General Brigham offers competitive base pay ranging from $96,886.40 to $140,899.20 annually along with comprehensive benefits.
Matching Summary
The role is responsible for optimizing drug therapy by identifying and resolving drug-related problems to improve patient outcomes.
Salary
Base: $96,886.40 - $140,899.20/Annual; Bonus/Equity: Not specified; Benefits: Comprehensive benefits, career advancement, differentials, premiums, and bonuses included
Skills & Requirements
Must-have
Optimization of antineoplastic drug therapy
Development of pharmacy policies and procedures
Oversight of prospective audit programs
Collaboration with oncology service teams
Management of medication error prevention
Nice-to-have
Experience in CAR T-cell therapy contexts
Knowledge of proton therapy applications
Ability to work independently on committees
Participation in quality improvement initiatives
Training capabilities for healthcare professionals